Intended Use

The HeartFlow Analysis is an AI-based medical device software for the clinical quantitative and qualitative analysis of previously acquired Computed Tomography DICOM data for patients with suspected coronary artery disease. It provides anatomic data, plaque identification and characterization, as well as calculations of FFRCT, a coronary physiological simulation, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images. It supports risk assessment and functional evaluation of coronary artery disease.

Technology

HeartFlow Analysis uses AI and machine learning algorithms trained on large volumes of CT data to extract anatomical data and simulate coronary physiology (FFRCT) from coronary CT angiography images. It produces graphical and textual output for clinician interpretation and is designed as a non-invasive, DICOM-compatible software package accessed via internet connectivity.

Performance

The device underwent extensive validation including stress testing, repeatability testing, and clinical data evaluation through previous clinical trials to ensure its safety and effectiveness. Results from current and prior testing demonstrate that the device performs as well as legally marketed predicate devices and is acceptable for use.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/10/2021

    10 months
  • 2

    FDA Approval

    10/14/2022

Other devices from HeartFlow, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.